The Indian Space Research Organisation (ISRO) Chief, S Somnath, revealed his battle with cancer, which was diagnosed on the same day as the launch of India’s Aditya-L1 mission.
In an exclusive interview with Tarmak Media House, Somnath confirmed that a growth was detected during a routine scan. “There were some health issues during the Chandrayaan-3 mission launch. However, it was not clear to me at the time,” he said.
The diagnosis came as a shock to him, his family, and colleagues, who have been supporting him throughout this challenging period. On September 2, 2023, as India’s first space-based solar observatory, Aditya L1, embarked on its journey to study the Sun, Somnath underwent a scan that revealed a growth in his stomach.
This unexpected discovery led him to Chennai for further scans, confirming the presence of a hereditary disease. Within days, it was confirmed that he had a significant health challenge to confront alongside his professional responsibilities. Somnath underwent an operation followed by chemotherapy.
“It was a shock for the family. But now, I perceive cancer and its treatment as a solution,” he said, reflecting his remarkable strength of character and unwavering spirit. “I was uncertain about a complete cure at the time, I was undergoing the process,” he admitted, highlighting the ongoing nature of his battle against cancer.
Yet, his recovery has been nothing short of miraculous. After spending just four days in the hospital, he resumed his duties at ISRO, working from the fifth day without any pain.
“I will be undergoing regular checkups and scans. But, now I am completely cured, and have resumed my duties,” Somnath said, ending the interview on a hopeful note.
Also Read: LS Polls 2024: Suspense Over Vadodara Seat Continues
